For decades, we have been taught to think about mental illness primarily as a problem inside the brain.

Depression became a serotonin problem.
Anxiety became a neurotransmitter problem.
ADHD became a dopamine problem.
And treatment often focused on changing brain chemistry with medication.

But the human brain does not exist in isolation.

It is connected to the immune system, the gut, the thyroid, the reproductive hormones, blood sugar regulation, mitochondria, sleep, nutritional status, the stress response system, and the nervous system. It is shaped by our relationships, our environment, our experiences, and the conditions in which our bodies have learned to survive.

When any of these systems changes, the brain changes with it.

That means symptoms we call “mental” can sometimes have very physical contributors.

Iron deficiency can affect dopamine production.
Thyroid dysfunction can resemble depression.
Blood sugar instability can feel remarkably similar to anxiety.
Sleep deprivation can dramatically alter mood and emotional regulation.
Hormonal shifts can change anxiety, cognition, motivation, and sleep.
Chronic inflammation can influence the brain and behavior.
Trauma can recalibrate the body's stress-response systems long after the original danger has passed.

None of this means depression, anxiety, bipolar disorder, ADHD, PTSD, or other psychiatric conditions have one simple biological cause.

Quite the opposite.

Modern research increasingly points toward multiple interacting pathways — genetics, neurotransmitters, neuroplasticity, inflammation, metabolism, hormones, nutrition, sleep, stress, trauma, social environment, and more.

And this is where the old idea of a simple “chemical imbalance” becomes inadequate.

A major 2022 review of the serotonin literature found that the evidence does not support the popular claim that depression is simply caused by low serotonin.

That does not mean serotonin is irrelevant.

And it does not mean antidepressants cannot work.

Psychiatric medications can be extremely valuable, and for some people they can be life-changing or lifesaving. But the fact that a medication changes neurotransmitter signaling does not prove that the illness was originally caused by a deficiency of that neurotransmitter.

Painkillers can relieve a headache without the headache being caused by a painkiller deficiency.

The same distinction matters in psychiatry.

Instead of asking only:

“Which neurotransmitter is out of balance?”

We should also be asking:

What is influencing the brain in the first place?

Is the person sleeping?

Are they iron deficient?

Is their thyroid functioning normally?

Are hormones changing?

Is blood sugar unstable?

Is chronic inflammation present?

Is the nervous system living in persistent threat?

Has trauma altered the stress response?

Are medications, substances, nutritional deficiencies, illness, isolation, or metabolic dysfunction contributing?

And, importantly, what psychological, social, genetic, and environmental factors are part of the picture?

Mental illness is real.

Its biology is real.

But that biology is far more complex than a single chemical being too high or too low.

The brain is an organ embedded within an entire human being — and understanding mental health requires understanding the whole system.

That broader perspective does not replace psychiatry.

It expands it.

And it opens the door to something incredibly important:

Instead of simply asking how we can suppress a symptom, we can begin asking what combination of biological, psychological, and social factors may be creating or sustaining it — and which of those factors can actually be changed.

This guide explores that bigger picture. 

 𝗪𝗛𝗔𝗧 𝗡𝗘𝗨𝗥𝗢𝗧𝗥𝗔𝗡𝗦𝗠𝗜𝗧𝗧𝗘𝗥𝗦 𝗔𝗖𝗧𝗨𝗔𝗟𝗟𝗬 𝗧𝗘𝗟𝗟 𝗨𝗦 — 𝗔𝗡𝗗 𝗪𝗛𝗔𝗧 𝗧𝗛𝗘𝗬 𝗗𝗢 𝗡𝗢𝗧

The chemical imbalance model emerged from two observations in the 1950s. A blood pressure medication called reserpine was noticed to cause depression in some patients — and reserpine depletes monoamine neurotransmitters like serotonin and dopamine. Around the same time, the first antidepressants were discovered to increase these same neurotransmitters in the brain and to reduce depression symptoms. From these two observations, a hypothesis was built. And that hypothesis became clinical doctrine faster than the evidence warranted.

What the evidence actually shows is more nuanced. Direct measurement of serotonin and its breakdown products in the cerebrospinal fluid of depressed people has not consistently found lower levels than in non-depressed people. Studies that temporarily reduce serotonin availability do reliably worsen mood in people who have previously been depressed — but do not consistently cause depression in healthy people without a prior history. If depression were simply caused by low serotonin, reducing serotonin should cause depression in anyone. It does not.

The timing problem is equally telling. Antidepressants raise serotonin in the brain within hours — but their mood effects, when they occur, take four to six weeks to develop. If the mechanism were simply "low serotonin causes depression, raise serotonin, feel better," the effect should be rapid. The delay strongly suggests the actual mechanism involves downstream changes — new connections forming in the brain, the growth of nerve cells in the hippocampus, the production of neuroplasticity proteins — rather than simple serotonin restoration.

And the response rates tell their own story. SSRIs produce complete remission in roughly 30–40% of patients who try them. Another 10–20% receive partial benefit. Around 30% receive no measurable benefit at all. If depression were a straightforward serotonin deficiency, effective serotonin restoration should help virtually everyone. It does not — because most depression is not primarily a serotonin deficiency.

None of this means neurotransmitters are unimportant. Serotonin, dopamine, norepinephrine, GABA, and glutamate are all genuinely involved in mental health. But they are downstream — they are the output of a complex biological system rather than the primary input driving it. Changing neurotransmitter levels without addressing what is driving them upstream is like turning down the volume on a smoke alarm rather than finding the fire. The alarm quiets. The fire continues.

The upstream drivers — the biological processes that determine whether neurotransmitter systems function well or poorly — are where the genuine causes of most mental illness reside. And those drivers are far more accessible, far more modifiable, and far more amenable to comprehensive intervention than the chemical imbalance model ever suggested.

www.shapeupforlife.com